Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 2:12:e75628.
doi: 10.7554/eLife.75628.

Investigating the composition and recruitment of the mycobacterial ImuA'-ImuB-DnaE2 mutasome

Affiliations

Investigating the composition and recruitment of the mycobacterial ImuA'-ImuB-DnaE2 mutasome

Sophia Gessner et al. Elife. .

Abstract

A DNA damage-inducible mutagenic gene cassette has been implicated in the emergence of drug resistance in Mycobacterium tuberculosis during anti-tuberculosis (TB) chemotherapy. However, the molecular composition and operation of the encoded 'mycobacterial mutasome' - minimally comprising DnaE2 polymerase and ImuA' and ImuB accessory proteins - remain elusive. Following exposure of mycobacteria to DNA damaging agents, we observe that DnaE2 and ImuB co-localize with the DNA polymerase III β subunit (β clamp) in distinct intracellular foci. Notably, genetic inactivation of the mutasome in an imuBAAAAGG mutant containing a disrupted β clamp-binding motif abolishes ImuB-β clamp focus formation, a phenotype recapitulated pharmacologically by treating bacilli with griselimycin and in biochemical assays in which this β clamp-binding antibiotic collapses pre-formed ImuB-β clamp complexes. These observations establish the essentiality of the ImuB-β clamp interaction for mutagenic DNA repair in mycobacteria, identifying the mutasome as target for adjunctive therapeutics designed to protect anti-TB drugs against emerging resistance.

Keywords: Mycobacterium smegmatis; Mycobacterium tuberculosis; anti-evolution; antibiotic resistance; biochemistry; chemical biology; induced mutagenesis; infectious disease; microbiology; mutasome.

PubMed Disclaimer

Conflict of interest statement

SG, ZM, MR, JS, RD, AR, ND, Td, SA, DL, JA, TC, JH, RM, JM, RW, VM, ČV, ML, DW No competing interests declared

Figures

Figure 1.
Figure 1.. Visualization of the mycobacterial mutasome components.
Representative stills from fluorescence microscopy experiments of M. smegmatis expressing translational reporters of the different mutasome components in their respective knockout backgrounds. Phase-contrast and fluorescence images of M. smegmatis expressing (i) G-imuB, (ii) V-imuA′, and (iii) G-dnaE2 alleles are represented following 4 hr exposure to ultra-violet (UV) and 1× minimun inhibitory concentration (MIC) mitomycin C (MMC). White boxes indicate zoomed-in regions shown in the panels at right. The far right-hand panels indicate the fluorescence intensity determined along the longitudinal axis of a representative cell from each reporter mutant; the specific cell analyzed is outlined in the corresponding image to the left of the graph. Fluorescence microscopy experiments were repeated two to four times. Scale bars, 5 µm. Source data are available in Figure1.zip which can be accessed at http://doi.org/10.5061/dryad.76hdr7szc.
Figure 1—figure supplement 1.
Figure 1—figure supplement 1.. Design and representative fluorescent images of the mutasome translational reporters.
(A) Construction of the reporter mutants, indicating: (i) the genomic organization of the wild-type M. smegmatis imuA′–imuB operon; (ii) the PSOS(imuA′)-egfp-imuB construct encoding G-ImuB; (iii) the design of the V-imuA′ gene utilizing the native imuA′ promoter to control expression of a single VFP-ImuA′-encoding ORF; and (iv) the egfp-dnaE2 allele used in the G-DnaE2 reporter. (B) Representative brightfield and fluorescent images of wild-type, V-ImuA′, G-ImuB, and G-DnaE2 translational reporter strains untreated (left panel), and following exposure to ultra-violet (UV) (middle panel) or 1× MIC mitomycin C (MMC) (right panel). Scale bars, 5 μm.
Figure 2.
Figure 2.. Functional validation of translational reporters.
(A) N-terminally tagged fluorescence reporter mutants of M. smegmatis ImuA′, ImuB, and DnaE2 retain function in DNA damage-induced mutagenesis. Cultures of M. smegmatis deletion mutants and complemented derivatives were exposed to 25 mJ/cm2 of 254 nm ultra-violet (UV) light and allowed to recover for 3 hr before selection of rifampicin (RIF)-resistant mutants on RIF-containing 7H10 solid agar plates. (i) Mutation frequencies were calculated as a fraction of the CFU/ml of each culture prior to exposure to UV irradiation. Complementation with the corresponding fluorescence reporter alleles restored the resistance frequencies of the three mutasome knockout mutants (ΔimuA′, ΔimuB, and ΔdnaE2) to levels observed in wild-type M. smegmatis. (ii) Representative RIF-containing plates with RIF-resistant mutants. (B) The same strains were exposed to 0.5× MIC mitomycin C (MMC) for 6 hr before plating on RIF-containing 7H10 solid plates. (i) Mutation frequencies were calculated as a fraction of the CFU/ml of each culture prior to exposure to MMC. As for the UV-induced mutagenesis assay, the fluorescence reporter alleles restored mutation frequencies to wild-type levels. (ii) Representative images of the RIF-containing plates with RIF-resistant mutants. (C) Serial dilutions of M. smegmatis deletion mutants and complemented strains were spotted on standard 7H10 and MMC-containing 7H10 plates. Results represent a minimum of three replicates for each strain. Source data are available in Figure2.zip which can be accessed at http://doi.org/10.5061/dryad.76hdr7szc.
Figure 2—figure supplement 1.
Figure 2—figure supplement 1.. V-ImuA’ and G-ImuB fluorescent bioreporters restore ultra-violet (UV)-induced DNA damage sensitivities of the corresponding ΔimuA’ and ΔimuB deletion mutants.
For this assay, a 10-fold dilution series was spotted on standard, antibiotic-free 7H10 plates, allowed to dry, and then exposed to UV at the indicated doses, after which plates were incubated at 37°C for 3 days and imaged.
Figure 3.
Figure 3.. Representative time-lapse series of single cells of M. smegmatis expressing the mutasome reporters in combination with mCherry-DnaN.
(A) G-ImuB (green) and mCherry-DnaN (magenta), (B) V-ImuA′ (green) and mCherry-DnaN (magenta), and (C) G-DnaE2 (green) and mCherry-DnaN (magenta). Overlapping signals are viewed as white. The cells were exposed to 0.5× MIC MMC from time 0 hr until 4.5 hr, after which the medium was switched back to standard 7H9/OADC medium. Up to 80 XY points were imaged at 10-min intervals on fluorescence and phase channels for up to 36 hr. The experiments were repeated two to four times. Numbers indicate hours elapsed; scale bars, 5 μm. 7H9, Middlebrook 7H9 medium; MMC, mitomycin C. (D) Population-scale analysis of cells with both mCherry-DnaN foci and G-ImuB foci showed distinct overlap in location suggesting co-occurrence of the respective proteins. Source data are available in Figure3.zip which can be accessed at http://doi.org/10.5061/dryad.76hdr7szc.
Figure 3—figure supplement 1.
Figure 3—figure supplement 1.. mCherry-DnaN and G-ImuB focus formation following DNA damage treatment.
(A) Frequency of mCherry-DnaN (top panel) and G-ImuB (bottom panel) foci following different DNA damage treatments. (B) Population analysis of cells with foci showing the proportion of cells containing either mCherry-DnaN or G-ImuB alone, mCherry-DnaN and G-ImuB located within 0.3 µm of each other, or mCherry-DnaN and G-ImuB located further than 0.3 µm apart. MMC, mitomycin C; GRS, griselimycin.
Figure 3—figure supplement 2.
Figure 3—figure supplement 2.. Formation of fluorescent EGFP-ImuB foci in the absence of functional mutasome components.
Each panel represents the expression of EGFP-ImuB foci following 1× MIC mitomycin C (MMC) treatment in different genetic backgrounds: (A) ΔimuA′, (B) dnaE2AIA, and (C) ΔdnaE2. Scale bars, 5 μm.
Figure 4.
Figure 4.. ImuB and ImuA′–ImuB interact with DnaN and these interactions are disrupted by griselimycin (GRS).
(A) Gel filtration profiles of M. smegmatis (i) ImuA′B-DnaN and (ii) ImuB-DnaN complexes in the absence or presence of 15 μM GRS. For these experiments, 5 μM DnaN was added to 10 μM of (i) ImuA′B or (ii) ImuB. The gel filtration profiles of the individual proteins (ImuB and DnaN) or complex (ImuA′–ImuB) are shown for comparative purposes, and all curves were scaled for clarity. (B) Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) analysis of sequential fractions of the gel filtration runs. Gels are sorted in the same order as the corresponding gel filtration profiles shown in A. Source data are available in Figure4.zip which can be accessed at http://doi.org/10.5061/dryad.76hdr7szc.
Figure 4—figure supplement 1.
Figure 4—figure supplement 1.. Biochemical confirmation of stable ImuA′–ImuB complex formation and griselimycin (GRS)-binding DnaN.
(A) M. smegmatis ImuA′ and ImuB form a stable complex. Gel filtration profiles of the ImuA′B complex at 14 μM (solid line) and 0.4 μM (dashed line) show identical elution volumes, indicating that the complex does not dissociate at these concentrations. For purposes of comparison, the gel filtration profiles were scaled. (B) His-GFP-ImuB and Strep-YFP-ImuA′ were co-expressed in E. coli and three steps of purification were performed. The lysate was initially loaded on a His-trap column and the ImuA′–ImuB complex was eluted with an imidazole gradient (His). Next, the His-Trap elution fractions were loaded on a Strep-trap column and ImuA′–ImuB complex was eluted using a desthiobiotin gradient (Strep). Lastly, the Strep-trap’s elution fraction was loaded in a size-exclusion chromatography column (SEC). Throughout all chromatography steps ImuB and ImuA′ were eluted together as a stable complex. His-GFP-ImuB and Strep-YFP-ImuA′ corresponding bands are indicated. (C) GRS binds M. smegmatis DnaN. (i) Melting curve of DnaN (5 μM) in the absence (dashed line) and presence (solid line) of 15 μM GRS. Addition of GRS results in an increase of 3°C in the protein melting temperature. (ii) Melting curve of ImuA′–ImuB complex (5 μM) in the absence (dashed line) and presence (solid line) of GRS. Addition of GRS (15 μM) does not alter the protein melting temperature (54.3°C).
Figure 5.
Figure 5.. Disrupting the ImuB–β clamp interaction.
(A) Representative images of G-ImuB exposed to 2× MIC mitomycin C (MMC) for 4 hr (top panel) or 2× MIC MMC plus griselimycin (GRS) for 4 hr (center panel), and the G-ImuBAAAAGG mutant exposed to 2× MIC MMC for 4 hr (bottom panel). Scale bars, 5 μm. (B) Interactions of M. smegmatis β clamp with (i) GRS, (ii) ImuB, or (iii) the replicative DNA PolIIIα subunit, DnaE1. The interaction of the β clamp with GRS is represented by the X-ray structure of the complex (PDB id: 5AGU). Predicted interactions with ImuB (S347-I359) and DnaE1 (M947-G954) are derived from the respective AlphaFold models. Interacting peptides are shown as smoothed traces with side chains. The brown β clamp region indicates residues in contact with corresponding peptides. Molecular contacts were derived from 3D structures using the VoroContacts web server. Detailed contact data are provided separately (Supplementary file 1 – DnaN Contact Data). (C) Cells aligned by mid-cell position, arranged according to cell length and colored (magenta – mCherry-DnaN foci, green – G-ImuB foci) according to fluorescence intensity, showing the presence of G-ImuB foci following MMC treatment and the lack of foci after GRS exposure. G-ImuBAAAAGG shows no foci after MMC treatment, similar to the G-ImuB strain following GRS exposure. (D) Proportions of cells containing either mCherry-DnaN or G-ImuB foci following exposure to GRS alone at 2× MIC or 5× MIC, or in combination with either single-dose ultra-violet (UV) or MMC at 2× MIC or 5× MIC. Additional Source data are available in Figure5.zip, accessible at http://doi.org/10.5061/dryad.76hdr7szc.
Figure 5—figure supplement 1.
Figure 5—figure supplement 1.. Comparison of M. smegmatis and M. tuberculosis β sliding clamps bound to griselimycin (GRS) crystal structures.
(A) M. smegmatis β clamp bound to GRS (PDB id: 5AH2). Each DnaN monomer is represented by a different color and each monomer is bound to GRS which is represented in blue and green. (B) Superimposed structures of M. smegmatis and M. tuberculosis. (C) M. tuberculosis β clamp bound to GRS (PDB id: 5AGU). Each DnaN monomer is represented by a different color and each monomer is bound to GRS which is represented in blue and green.

Update of

References

    1. Adefisayo OO, Dupuy P, Nautiyal A, Bean JM, Glickman MS. Division of labor between SOS and PafBC in mycobacterial DNA repair and mutagenesis. Nucleic Acids Research. 2021;49:12805–12819. doi: 10.1093/nar/gkab1169. - DOI - PMC - PubMed
    1. Bargonetti J, Champeil E, Tomasz M. Differential toxicity of DNA adducts of mitomycin C. Journal of Nucleic Acids. 2010;2010:698960. doi: 10.4061/2010/698960. - DOI - PMC - PubMed
    1. Barrett TC, Mok WWK, Murawski AM, Brynildsen MP. Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic. Nature Communications. 2019;10:1177. doi: 10.1038/s41467-019-09058-4. - DOI - PMC - PubMed
    1. Boritsch EC, Brosch R. Evolution of mycobacterium tuberculosis: New insights into pathogenicity and drug resistance. Microbiology Spectrum. 2016;4:495–515. doi: 10.1128/microbiolspec.TBTB2-0020-2016. - DOI - PubMed
    1. Bosch B, DeJesus MA, Poulton NC, Zhang W, Engelhart CA, Zaveri A, Lavalette S, Ruecker N, Trujillo C, Wallach JB, Li S, Ehrt S, Chait BT, Schnappinger D, Rock JM. Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis. Cell. 2021;184:4579–4592. doi: 10.1016/j.cell.2021.06.033. - DOI - PMC - PubMed

Publication types

MeSH terms